Christopher Mutz - 15 Feb 2022 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz
Issuer symbol
ANIP
Transactions as of
15 Feb 2022
Net transactions value
-$47,656
Form type
4
Filing time
17 Feb 2022, 18:24:41 UTC
Next filing
28 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $47,656 -1,184 -7.3% $40.25 14,950 15 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,033 shares of restricted stock, the grant of which was previously reported.